Inventor · Boston, MA, US

Kyle MacBeth

25Patents
6h-index
48Co-inventors
69Inventor score

Filing activity: Nov 14, 1997 → Jul 2, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US6300092A Methods of use of a novel lysyl oxidase-related protein Human Necessities 20 Expired
US9499514B2 Antiproliferative compounds and methods of use thereof Chemistry; Metallurgy 19 Active
US6872811B1 HRPCa9 and HRPCa10 nucleic acids and polypeptides Chemistry; Metallurgy 18 Expired
US7301016B2 Human transferase family members and uses thereof Chemistry; Metallurgy 10 Expired
US9808451B2 Antiproliferative compounds and methods of use thereof Chemistry; Metallurgy 9 Active
US5932422A Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase Human Necessities 7 Expired
US9968596B2 Antiproliferative compounds and methods of use thereof Chemistry; Metallurgy 6 Active
US10695352B2 Combination therapy for treating malignancies Human Necessities 4 Active
US10245258B2 Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide Human Necessities 4 Active
US8841277B2 Methods for treating non-small cell lung cancer using 5-azacytidine Human Necessities 4 Active
US7485308B2 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor Emerging Cross-Sectional Technologies 3 Active
US10996215B2 Methods for determining drug efficacy for the treatment of diffuse large B-cell lymphoma, multiple myeloma, and myeloid cancers Physics 3 Active
US9125884B2 Methods for treating cancers using oral formulations of cytidine analogs Human Necessities 2 Active
US10653710B2 Combination therapy for treating malignancies Human Necessities 2 Active
US11241423B2 Antiproliferative compounds and methods of use thereof Chemistry; Metallurgy 1 Active
US7098015B2 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor Physics 1 Expired
US9693987B2 Methods for treating cancers using oral formulations of cytidine analogs Human Necessities 1 Active
US7071004B1 14094, a novel human trypsin family member and uses thereof Physics 1 Expired
US6322982A Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase Human Necessities 0 Expired
US9101579B2 Inhibition of drug resistant cancer cells Human Necessities 0 Active
US6369210B1 22012, human carboxypeptidase Chemistry; Metallurgy 0 Expired
US8492361B2 Methods for treating non-small cell lung cancer using 5-azacytidine Human Necessities 0 Active
US11590117B2 Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide Human Necessities 0 Active
US7235634B2 2786, a novel human aminopeptidase Human Necessities 0 Expired
US6383780B1 2786, a novel human aminopeptidase Human Necessities 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.